BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,251 | +157.8% | 28,413 | -25.5% | 0.03% | +64.7% |
| Q4 2022 | $290,596 | +56.2% | 38,136 | +103.8% | 0.02% | +41.7% |
| Q3 2022 | $186,000 | -72.5% | 18,708 | -74.9% | 0.01% | -52.0% |
| Q2 2022 | $676,000 | +327.8% | 74,400 | +378.1% | 0.02% | +316.7% |
| Q1 2022 | $158,000 | -79.7% | 15,560 | -66.7% | 0.01% | -82.9% |
| Q4 2021 | $779,000 | +215.4% | 46,695 | +785.9% | 0.04% | +150.0% |
| Q3 2021 | $247,000 | – | 5,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |